1News 1News: your global news briefing, coming soon on iOS & Android
Coming Soon
Back to Business
Raymond James reiterates Vir Biotechnology stock rating on hepatitis delta data
Business September 28, 2026 at 6:54 PM

Raymond James reiterates Vir Biotechnology stock rating on hepatitis delta data

Investing.com
Read the full story at Investing.com
More Stories
Franklin International Growth Fund Q2 2026 Commentary
Business
Franklin International Growth Fund Q2 2026 Commentary
🇺🇸 Seeking Alpha 23m ago
MongoDB: Selloff Is Overdone, But The Stock Still Isn't Cheap
Business
MongoDB: Selloff Is Overdone, But The Stock Still Isn't Cheap
🇺🇸 Seeking Alpha 24m ago
Brixmor Property Group Inc. (BRX) M&A Call Transcript
Business
Brixmor Property Group Inc. (BRX) M&A Call Transcript
🇺🇸 Seeking Alpha 29m ago
1News
Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play